GLP-1 medications like Ozempic and Zepbound are transforming chronic disease and weight management, with perimenopausal women ...

The only GLP-1 medication that is FDA-approved to treat sleep apnea is Zepbound; it likely does this by lowering your weight. "If you are not overweight, medications like semaglutide and ...

Eli Lilly reported second quarter earnings Thursday, a day after competitor Novo Nordisk missed earnings estimates by Wall ...

Everyone is allowed to have their own opinion. But it’s important for me to own my own narrative and tell my own story.” ...

The FDA clearance sets Novo’s medicine up a market battle with Madrigal Pharmaceuticals’ fast-selling Rezdiffra.

Eli Lilly is one of the top growing stocks at the moment. Learn the reasons why this might be a stock to consider.

At a time when shedding pounds may be just a shot away, WeightWatchers is returning to its roots and its community to chart a ...

As Eli Lilly and Novo Nordisk have been battling it out to gain market share of the growing GLP-1 weight loss market, one ...